Cg Oncology Inc.
CGON
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.47B
Close$
$-3.68
106% downside
Current Fair Value
106% downsideOvervalued by 106% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.47 Billion |
|---|---|
| Enterprise Value | $5.46 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.08 |
| Beta | 0.24 |
| Outstanding Shares | 88,200,023 |
Return
| Return on Equity | -11.70% |
|---|---|
| Return on Assets | -11.09% |
| Return on Invested Capital | -22.91% |
Valuation & Multiples
| P/E Ratio | -22.86 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 5.61 |
| Enterprise Value to Revenue | 876.59 |
| Enterprise Value to EBIT | -22.95 |
| Enterprise Value to Net Income | -46 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$360,805
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.81
Average shareholder expectationRevenue Estimate
$491,235
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 36.75% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.10%▼ 111.66% |
|---|---|
| Total Invested | $6.15M▼ 99.91% |
| Investors Holding | 10▼ 236.00% |
ESG Score
No data